Spots Global Cancer Trial Database for A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)
Official Title: A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer
Study ID: NCT02985957
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate cancer (mCRPC).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Local Institution - 0074, Tucson, Arizona, United States
Local Institution - 0046, Marietta, Georgia, United States
Local Institution - 0011, Chicago, Illinois, United States
Local Institution - 0076, Minneapolis, Minnesota, United States
Local Institution - 0008, Saint Louis, Missouri, United States
Local Institution - 0075, Las Vegas, Nevada, United States
Local Institution - 0078, Albany, New York, United States
Local Institution - 0065, Lake Success, New York, United States
Local Institution - 0001, New York, New York, United States
Local Institution - 0077, Tigard, Oregon, United States
Local Institution - 0047, Allentown, Pennsylvania, United States
Local Institution - 0010, Philadelphia, Pennsylvania, United States
Local Institution - 0067, Charleston, South Carolina, United States
Local Institution - 0079, Austin, Texas, United States
Local Institution - 0002, Houston, Texas, United States
Local Institution - 0027, Gosford, New South Wales, Australia
Local Institution - 0059, Wahroonga, New South Wales, Australia
Local Institution - 0029, Westmead, New South Wales, Australia
Local Institution - 0028, Southport, Queensland, Australia
Local Institution - 0043, Woolloongabba, Queensland, Australia
Local Institution - 0030, Elizabeth Vale, South Australia, Australia
Local Institution - 0031, Clayton, Victoria, Australia
Local Institution - 0048, Wien, , Austria
Local Institution - 0044, Montreal, Quebec, Canada
Local Institution - 0063, Aarhus N, Midtjylland, Denmark
Local Institution - 0062, Aalborg, , Denmark
Local Institution - 0061, Kobenhavn O, , Denmark
Local Institution - 0060, Odense, , Denmark
Local Institution - 0009, Clermont-ferrand, , France
Local Institution - 0005, Lyon, , France
Local Institution - 0004, Marseille Cedex 9, , France
Local Institution - 0003, Villejuif, , France
Local Institution - 0038, Göttingen, Niedersachsen, Germany
Local Institution - 0041, Braunschweig, , Germany
Local Institution - 0032, Dresden, , Germany
Local Institution - 0019, Herne, , Germany
Local Institution - 0017, Jena, , Germany
Local Institution - 0018, Muenster, , Germany
Local Institution - 0034, Munich, , Germany
Local Institution - 0037, Nuernberg, , Germany
Local Institution - 0042, Nuertingen, , Germany
Local Institution - 0036, Rostock, , Germany
Local Institution - 0033, Tuebingen, , Germany
Local Institution - 0035, Wesel, , Germany
Local Institution - 0071, Arezzo, , Italy
Local Institution - 0052, Milano, , Italy
Local Institution - 0053, Napoli, , Italy
Local Institution - 0072, Parma, , Italy
Local Institution - 0051, Terni, , Italy
Local Institution - 0055, Kraków, Małopolskie, Poland
Local Institution - 0066, Koszalin, , Poland
Local Institution - 0054, Warszawa, , Poland
Local Institution - 0022, Madrid, Sede Madrid, Spain
Local Institution - 0026, Badajoz, , Spain
Local Institution - 0025, Barcelona, , Spain
Local Institution - 0020, Madrid, , Spain
Local Institution - 0021, Madrid, , Spain
Local Institution - 0024, Malaga, , Spain
Local Institution - 0023, Santiago Compostela, , Spain
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
